Study Details

Back
Study ID 6981-CL-0004
Study Title A Phase 1 Randomized, 2-way, Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Patients with Schizophrenia
Clinicaltrials.gov Identifier NCT03356639
Compound Name ASP6981
Medical Indication or Disease Schizophrenia
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Not Applicable
Study Start Date 22-Jan-2018
Study Completion Date 30-May-2018
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS